The Wavstat4 part of a $1,133,514 project Converted to

New Post Public Reply Private Reply Replies (1) Message Board
joey68
The Wavstat4 part of a $1,133,514 project

Converted to pounds, its £791,367.

Go here:
http://www.nihr.ac.uk/about/healthcare-techno...atives.htm

Look at the third link down:
Quote:
NIHR Colorectal Therapies Healthcare Technology Co-operative


Quote:
Building on the pilot scheme, the NIHR launched an open competition in January 2012, after which eight new HTCs were launched on 1 January 2013, and will receive £6.4 million of funding over four years.


SCIE is part of the 3rd HTC (3rd link down).
This takes you back to the page from the previous post.
This shows that SpectraScience is indeed part of a $1 million+ program designed to develop new medical devices

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 20

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 22

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 16

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 10

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 25

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 11

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 21

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Sea-Doo Urges Riders to Embrace Safety This Summer Season

Updated Category News Views 126

Sea-Doo Promotes Water Safety for All Riders As summer approaches, Sea-Doo, the renowned brand under BRP Inc. (TSX: DOO) (NASDAQ: DOOO), is reaching out to all watercraft enthusiasts, urging them to take safety seriously. The iconic company emphasizes the importance of responsible riding and has rolled out initiatives to foster a culture of safety among boaters and...

Continue Reading
Understanding the Upcoming Class Action for Vestis Corporation

Updated Category News Views 160

Vestis Corporation and Upcoming Class Action Lawsuit Vestis Corporation (NYSE: VSTS) is currently in the spotlight as investors are reminded of a significant deadline pertaining to a class action lawsuit that has been initiated against the company. This lawsuit concerns allegations of securities fraud, and its implications are pertinent to all shareholders of Vestis. What...

Continue Reading
infinitii ai's Strategic Vision for U.S. Market Expansion

Updated Category News Views 112

Overview of infinitii ai's Annual General Meeting At the recent Annual General Meeting, infinitii ai inc. shared exciting updates regarding their financial performance and strategic direction for the future. The company reported impressive growth and ongoing initiatives aimed at expanding its influence in the U.S. market, positioning itself for success in upcoming fiscal...

Continue Reading
AGF Management to Announce Q1 2025 Results and Insights

Updated Category News Views 215

AGF Management Limited to Release Q1 2025 Financial Results AGF Management Limited (TSX: AGF) is preparing to unveil its financial results for the first quarter of 2025 on April 8 at around 7:00 a.m. ET. This announcement is anticipated as the company shares its insights into the recent fiscal performance. Conference Call and Webcast Details This upcoming release will be...

Continue Reading
Analyst Insights Prepare Investors for Applied Digital's Q2 Earnings

Updated Category News Views 101

Applied Digital's Upcoming Earnings Release Applied Digital Corporation (NASDAQ: APLD) is gearing up to announce its earnings results for the second quarter. Investors and analysts alike are keenly awaiting this information, especially considering the significance it carries for the company's future performance. Analysts' Forecasts and Expectations The company is...

Continue Reading